CIK 0001844417 · <br>Emerging growth company
Estrella Immunopharma, Inc.
Sign in to watch- Ticker
- ESLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861314502
- Phone
- (510) 318-9098
- Business address
- 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
- Former names
- TradeUP Acquisition Corp.
Securities
- ESLA Common Stock Nasdaq
- ESLAW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-07 | Xu Jiandong Chief Financial Officer | Purchase | +1,000 | $1.33 | $1K | 265,488 |
| 2025-09-22 | Xu Jiandong Chief Financial Officer | Purchase | +1,000 | $1.16 | $1K | 16,700 |
| 2025-09-11 | Xu Jiandong Chief Financial Officer | Purchase | +100 | $1.04 | $104 | 264,588 |
| 2022-03-04 | Li Jianwei Co-Chief Executive Officer | Purchase | +141,970 | $314,700.00 | $44.7B | 1,253,730 |
Page 1 of 1 · 4 trades